23andMe to delist from Nasdaq, deregister with SEC

A sign is posted in front of the 23andMe headquarters in Sunnyvale, California, on Feb. 1, 2024.

Justin Sullivan | Getty Images

23andMe on Tuesday announced it will voluntarily delist from the Nasdaq and de-register with the U.S. Securities and Exchange Commission, according to a release.

The move comes after Regeneron Pharmaceuticals said earlier this month that it will acquire “substantially all” of 23andMe’s assets for $256 million.

The drugmaker came out on top following a bankruptcy auction for 23andMe, a once high-flying genetic testing company that filed for for Chapter 11 bankruptcy protection in March.

This is breaking news. Please refresh for updates.

Source

Technology

Stocks end November with mixed results despite a strong Thanksgiving week rally

November 28, 2025

A Thanksgiving week rally couldn’t put all three major indexes in the green for November. The S & P 500 gained nearly 4% for the week, while the Dow Jones Industrial Average added more than 3% — a strong enough showing for each to eke out gains for the month. It extends their streak of […]

Technology

Palantir has worst month in two years as AI stocks selloff

November 28, 2025

CEO of Palantir Technologies Alex Karp attends the Pennsylvania Energy and Innovation Summit, at Carnegie Mellon University in Pittsburgh, Pennsylvania, U.S., July 15, 2025. Nathan Howard | Reuters It’s been a tough November for Palantir. Shares of the software analytics provider dropped 16% for their worst month since August 2023 as investors dumped AI stocks […]

Technology

CME disruption, Black Friday, the K-beauty boom and more in Morning Squawk

November 28, 2025

CME Group sign at NYMEX in New York. Adam Jeffery | CNBC This is CNBC’s Morning Squawk newsletter. Subscribe here to receive future editions in your inbox. Here are five key things investors need to know to start the trading day: 1. Down and out Stock futures trading was halted this morning after a data center “cooling […]